Donor-Derived iPS Cells Show Promise for Treating Eye Disease

April 30, 2019

(The Scientist) – The results of the first clinical trial using induced pluripotent stem cells from donors point to signs of efficacy for treating the progressive form of blindness known as age-related macular degeneration. Last week, the Japanese team of researchers reported that the first five patients to be treated are doing well and did not suffer further eyesight loss for at least a year after receiving the therapy in 2017, according toThe Japan Times. One patient’s eyesight even improved.